JP2017528279A - 自動注射器用ハウジング部分 - Google Patents
自動注射器用ハウジング部分 Download PDFInfo
- Publication number
- JP2017528279A JP2017528279A JP2017516775A JP2017516775A JP2017528279A JP 2017528279 A JP2017528279 A JP 2017528279A JP 2017516775 A JP2017516775 A JP 2017516775A JP 2017516775 A JP2017516775 A JP 2017516775A JP 2017528279 A JP2017528279 A JP 2017528279A
- Authority
- JP
- Japan
- Prior art keywords
- syringe
- housing
- needle
- shell
- covering
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229940090047 auto-injector Drugs 0.000 claims abstract description 39
- 239000000463 material Substances 0.000 claims abstract description 37
- 239000012669 liquid formulation Substances 0.000 claims description 27
- 229920002725 thermoplastic elastomer Polymers 0.000 claims description 11
- 239000011248 coating agent Substances 0.000 claims description 5
- 238000000576 coating method Methods 0.000 claims description 5
- 229920005996 polystyrene-poly(ethylene-butylene)-polystyrene Polymers 0.000 claims description 5
- XECAHXYUAAWDEL-UHFFFAOYSA-N acrylonitrile butadiene styrene Chemical compound C=CC=C.C=CC#N.C=CC1=CC=CC=C1 XECAHXYUAAWDEL-UHFFFAOYSA-N 0.000 claims description 4
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 claims description 4
- 239000004676 acrylonitrile butadiene styrene Substances 0.000 claims description 4
- 229920001400 block copolymer Polymers 0.000 claims description 4
- FACXGONDLDSNOE-UHFFFAOYSA-N buta-1,3-diene;styrene Chemical compound C=CC=C.C=CC1=CC=CC=C1.C=CC1=CC=CC=C1 FACXGONDLDSNOE-UHFFFAOYSA-N 0.000 claims description 4
- 239000007779 soft material Substances 0.000 claims description 4
- 229920000468 styrene butadiene styrene block copolymer Polymers 0.000 claims description 4
- 229920006342 thermoplastic vulcanizate Polymers 0.000 claims description 4
- 239000013011 aqueous formulation Substances 0.000 claims description 2
- BXOUVIIITJXIKB-UHFFFAOYSA-N ethene;styrene Chemical group C=C.C=CC1=CC=CC=C1 BXOUVIIITJXIKB-UHFFFAOYSA-N 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 claims description 2
- 239000004636 vulcanized rubber Substances 0.000 claims description 2
- 239000003124 biologic agent Substances 0.000 claims 1
- 238000002347 injection Methods 0.000 description 23
- 239000007924 injection Substances 0.000 description 23
- 230000005540 biological transmission Effects 0.000 description 19
- 230000007246 mechanism Effects 0.000 description 17
- 239000003814 drug Substances 0.000 description 13
- 238000000034 method Methods 0.000 description 13
- 229940079593 drug Drugs 0.000 description 12
- 230000008878 coupling Effects 0.000 description 9
- 238000010168 coupling process Methods 0.000 description 9
- 238000005859 coupling reaction Methods 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 230000006870 function Effects 0.000 description 8
- 230000002441 reversible effect Effects 0.000 description 8
- 238000012360 testing method Methods 0.000 description 7
- 230000008569 process Effects 0.000 description 6
- 230000035939 shock Effects 0.000 description 6
- 210000001364 upper extremity Anatomy 0.000 description 6
- 230000004913 activation Effects 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 229920001059 synthetic polymer Polymers 0.000 description 5
- 108010038807 Oligopeptides Proteins 0.000 description 4
- 102000015636 Oligopeptides Human genes 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 238000004146 energy storage Methods 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 229920005615 natural polymer Polymers 0.000 description 4
- 229920001184 polypeptide Polymers 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 108060003951 Immunoglobulin Proteins 0.000 description 3
- 102000015696 Interleukins Human genes 0.000 description 3
- 108010063738 Interleukins Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000007792 addition Methods 0.000 description 3
- 229920001971 elastomer Polymers 0.000 description 3
- 102000018358 immunoglobulin Human genes 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000005060 rubber Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 3
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- 102000018997 Growth Hormone Human genes 0.000 description 2
- 108010051696 Growth Hormone Proteins 0.000 description 2
- 229920002633 Kraton (polymer) Polymers 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000251131 Sphyrna Species 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 239000000356 contaminant Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000009970 fire resistant effect Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000002783 friction material Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 229940072221 immunoglobulins Drugs 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 208000027866 inflammatory disease Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 229920001427 mPEG Polymers 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 229920003052 natural elastomer Polymers 0.000 description 2
- 229920001194 natural rubber Polymers 0.000 description 2
- -1 polyethylene Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000003380 propellant Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229920003051 synthetic elastomer Polymers 0.000 description 2
- 239000005061 synthetic rubber Substances 0.000 description 2
- 201000000596 systemic lupus erythematosus Diseases 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 208000031261 Acute myeloid leukaemia Diseases 0.000 description 1
- 239000000275 Adrenocorticotropic Hormone Substances 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010002556 Ankylosing Spondylitis Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 208000020084 Bone disease Diseases 0.000 description 1
- 101100480513 Caenorhabditis elegans tag-52 gene Proteins 0.000 description 1
- 102000019034 Chemokines Human genes 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 102000007644 Colony-Stimulating Factors Human genes 0.000 description 1
- 108010071942 Colony-Stimulating Factors Proteins 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 102400000739 Corticotropin Human genes 0.000 description 1
- 101800000414 Corticotropin Proteins 0.000 description 1
- 208000011231 Crohn disease Diseases 0.000 description 1
- 229920000089 Cyclic olefin copolymer Polymers 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000003951 Erythropoietin Human genes 0.000 description 1
- 108090000394 Erythropoietin Proteins 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 208000009329 Graft vs Host Disease Diseases 0.000 description 1
- 208000035895 Guillain-Barré syndrome Diseases 0.000 description 1
- 208000031886 HIV Infections Diseases 0.000 description 1
- 208000002250 Hematologic Neoplasms Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102100026720 Interferon beta Human genes 0.000 description 1
- 102100037850 Interferon gamma Human genes 0.000 description 1
- 108090000467 Interferon-beta Proteins 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 102000003816 Interleukin-13 Human genes 0.000 description 1
- 108090000176 Interleukin-13 Proteins 0.000 description 1
- 102000013691 Interleukin-17 Human genes 0.000 description 1
- 108050003558 Interleukin-17 Proteins 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 102000004388 Interleukin-4 Human genes 0.000 description 1
- 108090000978 Interleukin-4 Proteins 0.000 description 1
- 108010002616 Interleukin-5 Proteins 0.000 description 1
- 102000000743 Interleukin-5 Human genes 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 102000004889 Interleukin-6 Human genes 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 229920006382 Lustran Polymers 0.000 description 1
- 108010074338 Lymphokines Proteins 0.000 description 1
- 102000008072 Lymphokines Human genes 0.000 description 1
- 208000029725 Metabolic bone disease Diseases 0.000 description 1
- 206010049567 Miller Fisher syndrome Diseases 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 1
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 1
- 108010025020 Nerve Growth Factor Proteins 0.000 description 1
- 102000015336 Nerve Growth Factor Human genes 0.000 description 1
- 206010049088 Osteopenia Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 102400000050 Oxytocin Human genes 0.000 description 1
- XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 description 1
- 101800000989 Oxytocin Proteins 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 102000001938 Plasminogen Activators Human genes 0.000 description 1
- 108010001014 Plasminogen Activators Proteins 0.000 description 1
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 1
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 208000036824 Psoriatic arthropathy Diseases 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 206010040070 Septic Shock Diseases 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000012867 bioactive agent Substances 0.000 description 1
- 201000000053 blastoma Diseases 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- MSYKRHVOOPPJKU-BDAKNGLRSA-N brivaracetam Chemical compound CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1 MSYKRHVOOPPJKU-BDAKNGLRSA-N 0.000 description 1
- 229960002161 brivaracetam Drugs 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000005253 cladding Methods 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 229960000258 corticotropin Drugs 0.000 description 1
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 239000013583 drug formulation Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 201000008184 embryoma Diseases 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 229940105423 erythropoietin Drugs 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 208000024908 graft versus host disease Diseases 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 208000036260 idiopathic disease Diseases 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 108040006732 interleukin-1 receptor activity proteins Proteins 0.000 description 1
- 102000014909 interleukin-1 receptor activity proteins Human genes 0.000 description 1
- 229940047122 interleukins Drugs 0.000 description 1
- 208000023589 ischemic disease Diseases 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000012764 mineral filler Substances 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 229940053128 nerve growth factor Drugs 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 229960001723 oxytocin Drugs 0.000 description 1
- XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 description 1
- 210000001428 peripheral nervous system Anatomy 0.000 description 1
- 229940127126 plasminogen activator Drugs 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920001281 polyalkylene Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000009993 protective function Effects 0.000 description 1
- 229920005604 random copolymer Polymers 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 229920003031 santoprene Polymers 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- ANWPENAPCIFDSZ-BQBZGAKWSA-N seletracetam Chemical compound CC[C@@H](C(N)=O)N1C[C@@H](C=C(F)F)CC1=O ANWPENAPCIFDSZ-BQBZGAKWSA-N 0.000 description 1
- 229950000852 seletracetam Drugs 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 208000007056 sickle cell anemia Diseases 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 206010041823 squamous cell carcinoma Diseases 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 206010044412 transitional cell carcinoma Diseases 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
- A61M5/2033—Spring-loaded one-shot injectors with or without automatic needle insertion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/3129—Syringe barrels
- A61M5/3137—Specially designed finger grip means, e.g. for easy manipulation of the syringe rod
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
- A61M5/31576—Constructional features or modes of drive mechanisms for piston rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/3202—Devices for protection of the needle before use, e.g. caps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/3205—Apparatus for removing or disposing of used needles or syringes, e.g. containers; Means for protection against accidental injuries from used needles
- A61M5/321—Means for protection against accidental injuries by used needles
- A61M5/3243—Means for protection against accidental injuries by used needles being axially-extensible, e.g. protective sleeves coaxially slidable on the syringe barrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M2005/3125—Details specific display means, e.g. to indicate dose setting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/02—General characteristics of the apparatus characterised by a particular materials
- A61M2205/0216—Materials providing elastic properties, e.g. for facilitating deformation and avoid breaking
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/02—General characteristics of the apparatus characterised by a particular materials
- A61M2205/0238—General characteristics of the apparatus characterised by a particular materials the material being a coating or protective layer
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Environmental & Geological Engineering (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Description
Claims (16)
- 内側殻面及び外側殻面を画定し、かつ相対的に硬質な材料又は略非圧縮性材料から構成される殻状本体と、
相対的に軟質な材料又はより高圧縮性材料から形成され、かつ前記殻状本体の外側殻面の少なくとも一部を覆う被覆体と、
前記殻状本体にて画定された少なくとも1つの窓であって、前記被覆体が少なくとも1つの窓内にて延びる、少なくとも1つの窓と
を備える自動注射器用ハウジング部分。 - 前記被覆体が、前記少なくとも1つの窓内にて少なくとも前記内側殻面の深さまで延びている、請求項1に記載のハウジング部分。
- 前記被覆体が、内側突出要素を画定するように前記窓内にて前記内側殻面の深さを超えて延びている、請求項2に記載のハウジング部分。
- 前記被覆体が、前記殻状本体へのオーバーモールド成形要素として設けられている、請求項1〜3のいずれか一項に記載のハウジング部分。
- 前記殻状本体がクラムシェル形状を有している、請求項1〜4のいずれか一項に記載のハウジング部分。
- 前記殻状本体が円筒状又は楕円体状のクラムシェル形状を有している、請求項5に記載のハウジング部分。
- 自動注射器用ハウジングの後方部分を画定する請求項1〜6のいずれか一項に記載のハウジング部分。
- 前記窓が前記ハウジングの後方部分の後端部側に設けられている、請求項7に記載のハウジング部分。
- 前記殻状本体がアクリロニトリルブタジエンスチレン材料から構成されている、請求項1〜8のいずれか一項に記載のハウジング部分。
- 前記被覆体が、熱可塑性エラストマー材料から構成されている、請求項1〜9のいずれか一項に記載のハウジング部分。
- 前記熱可塑性エラストマー材料が、スチレン−エチレン/ブチレン−スチレン(SEBS)ブロックコポリマー、スチレン−エチレン/プロピレン−スチレン(SEPS)ブロックコポリマー、スチレン−ブタジエン−スチレン(SBS)、及び加硫化ゴム介在物を含む熱可塑性加硫物(TPV)から選択されたものとなっている、請求項10に記載のハウジング部分。
- 前記被覆体が、20ショアAから60ショアAの硬度を有する材料から構成されている、請求項1〜11のいずれか一項に記載のハウジング部分。
- 請求項1〜12のいずれか一項に記載のハウジング部分と、シリンジとを備える自動注射器装置。
- 前記シリンジが液体製剤を収容するようになっている、請求項13に記載の自動注射器。
- 前記シリンジのバレルが、前記液体製剤の1回投与量に対応する容積を有している、請求項14に記載の自動注射器。
- 前記液体製剤が治療用生物学的薬剤の水性製剤を含む、請求項15に記載の自動注射器。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1416985.8 | 2014-09-26 | ||
GBGB1416985.8A GB201416985D0 (en) | 2014-09-26 | 2014-09-26 | Housing part for an auto-injector |
PCT/EP2015/071601 WO2016046131A1 (en) | 2014-09-26 | 2015-09-21 | Housing part for an anto-injector |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2017528279A true JP2017528279A (ja) | 2017-09-28 |
JP6461325B2 JP6461325B2 (ja) | 2019-01-30 |
Family
ID=51901143
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017516775A Active JP6461325B2 (ja) | 2014-09-26 | 2015-09-21 | 自動注射器用ハウジング部分 |
Country Status (9)
Country | Link |
---|---|
US (1) | US10918792B2 (ja) |
EP (1) | EP3197526B1 (ja) |
JP (1) | JP6461325B2 (ja) |
CN (1) | CN107073215B (ja) |
AU (1) | AU2015320956A1 (ja) |
BR (1) | BR112017006133B1 (ja) |
CA (1) | CA2960782C (ja) |
GB (1) | GB201416985D0 (ja) |
WO (1) | WO2016046131A1 (ja) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019237082A1 (en) | 2018-06-08 | 2019-12-12 | Antares Pharma, Inc. | Auto-insert injector |
EP3626291A1 (en) | 2018-09-21 | 2020-03-25 | Regeneron Pharmaceuticals, Inc. | Needle shield grip device |
CA3132163A1 (en) * | 2019-03-15 | 2020-09-24 | Eli Lilly And Company | Automatic injection system |
USD917064S1 (en) * | 2019-04-17 | 2021-04-20 | Christian Ribeiro | Ostomy cleaning tool |
USD965148S1 (en) * | 2021-01-20 | 2022-09-27 | Shenzhen DJ Innovation Industry Co., Ltd | Hydra needle |
USD1028220S1 (en) * | 2022-11-30 | 2024-05-21 | SYNERGY LIFE SCIENCE, Inc. | Portable nebulizer |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3052991U (ja) * | 1998-04-02 | 1998-10-13 | オージーケー技研株式会社 | ハンドルグリップ構造 |
JP2002518107A (ja) * | 1998-06-19 | 2002-06-25 | アボット・ラボラトリーズ | エラストマー製端部を備えた注入ポンプ用押出加工金属ハウジング |
JP2012082262A (ja) * | 2010-10-07 | 2012-04-26 | Kaneka Corp | 熱可塑性樹脂組成物および成形体 |
JP2013522481A (ja) * | 2010-03-12 | 2013-06-13 | エクソンモービル・ケミカル・パテンツ・インク | 耐熱性不織布を生成するための方法 |
WO2014033141A1 (en) * | 2012-08-31 | 2014-03-06 | Sanofi-Aventis Deutschland Gmbh | Medical device with impact resistant housing |
JP2014506493A (ja) * | 2011-01-24 | 2014-03-17 | アッヴィ バイオテクノロジー リミテッド | オーバーモールド把持面を有する自動注射器 |
Family Cites Families (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4333456A (en) | 1981-02-09 | 1982-06-08 | Sterling Drug Inc. | Self-aspirating hypodermic syringe and self-aspirating assembly therefor |
US4985000A (en) * | 1986-09-30 | 1991-01-15 | Minnesota Mining And Manufacturing Co. | Shielded cable termination assembly |
US6506195B2 (en) * | 1992-09-30 | 2003-01-14 | Staar Surgical Company, Inc. | Deformable intraocular lens insertion system |
US6454746B1 (en) | 1997-06-04 | 2002-09-24 | Eli Lilly And Company | Medication delivery apparatus |
US6223733B1 (en) * | 1997-07-08 | 2001-05-01 | Siemens Canada Limited | Exhaust gas recirculation valve |
US7455661B2 (en) | 1998-04-17 | 2008-11-25 | Becton, Dickinson And Company | Safety shield system for prefilled syringe |
AU2001285488A1 (en) * | 2000-08-28 | 2002-03-13 | Advanced Bio Surfaces, Inc | Method for mammalian joint resurfacing |
JP4163961B2 (ja) | 2001-03-27 | 2008-10-08 | イーライ リリー アンド カンパニー | 注入ペンカートリッジ内で薬品を用意するための横噴出注射器針を含むキット |
US6669664B2 (en) * | 2001-09-07 | 2003-12-30 | Avant Drug Delivery Systems, Inc. | Vacuum control cycle for jet injector |
US20050131355A1 (en) * | 2002-06-12 | 2005-06-16 | Fritz Kirchhofer | Injection or infusion device with refined surface |
AU2003253859A1 (en) * | 2002-07-08 | 2004-01-23 | Medical Instill Technologies, Inc. | Interadermal delivery device, and method of intradermal delivery |
AU2002336381A1 (en) * | 2002-08-26 | 2004-03-11 | Penjet Corporation | Apparatus for needle-less injection with a degassed fluid |
EP1715903B1 (en) | 2004-01-23 | 2007-10-24 | The Medical House Plc | Injection device |
IL162854A (en) | 2004-07-04 | 2011-08-31 | Igal Sharon | Syringe assembly |
WO2006077466A2 (en) * | 2005-01-18 | 2006-07-27 | Wockhardt Americas Inc | Pen shaped medication injection devices |
US20080195056A1 (en) * | 2005-06-21 | 2008-08-14 | Steven Bishop | Apparatus And Method For Injecting A Pharmaceutical |
US7647929B2 (en) | 2005-09-28 | 2010-01-19 | Nellcor Puritan Bennett Llc | Medical device tube having a flange with opposing support ears for improved alignment and retention of an inner cannula in an outer cannula |
GB0601309D0 (en) | 2006-01-23 | 2006-03-01 | Medical House The Plc | Injection device |
GB0625169D0 (en) | 2006-12-18 | 2007-01-24 | Medical House Plc The | Improved autoinjector |
US20080183133A1 (en) | 2007-01-30 | 2008-07-31 | Animas Corporation | Infusion pump keypad assembly and method for making the same |
FR2915079B1 (fr) * | 2007-04-20 | 2009-06-05 | E2V Semiconductors Soc Par Act | Capteur d'image radiologique dentaire avec surmoulage souple |
US8043075B2 (en) | 2007-06-19 | 2011-10-25 | Smiths Medical Asd, Inc. | Progressive cavity propagation pump |
US20090209883A1 (en) * | 2008-01-17 | 2009-08-20 | Michael Higgins | Tissue penetrating apparatus |
ATE489980T1 (de) | 2008-01-17 | 2010-12-15 | Peter Loos Und Arnold Neuhold Gewerbliche Schutzrechte Gbr | Kartusche für ein autoinjektor und system bestehend aus einer solchen kartusche und einem autoinjektor |
US8048029B2 (en) | 2008-06-20 | 2011-11-01 | West Pharmaceutical Services, Inc. | Injector apparatus |
DK2326371T3 (da) * | 2008-07-18 | 2019-11-18 | Ucb Biopharma Sprl | Systemer til indgift af medicin til patienter med rheumatoid arthritis |
GB2463071A (en) | 2008-09-02 | 2010-03-03 | Owen Mumford Ltd | Auto-injector syringe with safety shield |
GB0823066D0 (en) | 2008-12-18 | 2009-01-28 | Medical House Plc The | Safety syringe for autoinjector |
USD660958S1 (en) * | 2009-07-20 | 2012-05-29 | Ucb Pharma, S.A. | Device for administering medication |
EP2493532B1 (en) | 2009-10-30 | 2019-07-10 | Sanofi-Aventis Deutschland GmbH | Drug delivery device |
GB2475917B (en) | 2009-12-07 | 2015-12-16 | Medical House Ltd | Syringe flange protector |
FR2953676B1 (fr) | 2009-12-07 | 2012-06-08 | Orange Vallee | Procede, terminal et systeme de communication par messages non verbaux |
US9572937B2 (en) * | 2010-02-18 | 2017-02-21 | Sanofi-Aventis Deutschland Gmbh | Autoinjector having piston rod with non-circular axial bore slidably arranged on housing shaft to prevent relative rotation |
EP2536452B1 (en) * | 2010-02-18 | 2018-08-29 | Sanofi-Aventis Deutschland GmbH | Auto-injector |
DK3338833T3 (da) * | 2010-02-18 | 2020-10-19 | Sanofi Aventis Deutschland | Autoinjektor med en torsionsfjeder |
EP2364739A1 (en) * | 2010-03-09 | 2011-09-14 | Sanofi-Aventis Deutschland GmbH | Re-usable autoinjector |
EP2364740A1 (en) * | 2010-03-09 | 2011-09-14 | Sanofi-Aventis Deutschland GmbH | Arrangement for transferring a translation of a drive means to a plunger |
US20140290792A1 (en) | 2010-08-13 | 2014-10-02 | Sanofi-Aventis Deutschland Gmbh | Connector for a Drug Delivery Device Reservoir |
EP2438939A1 (en) * | 2010-10-08 | 2012-04-11 | Sanofi-Aventis Deutschland GmbH | Arrangement for coupling a plunger to either a syringe or a stopper |
TWI459986B (zh) | 2010-11-08 | 2014-11-11 | Shl Group Ab | 容器支撐總成 |
GB201021777D0 (en) * | 2010-12-22 | 2011-02-02 | Owen Mumford Ltd | Autoinjectors |
CA2833748C (en) | 2011-04-20 | 2019-07-16 | Amgen Inc. | Autoinjector apparatus |
AU2012245211B2 (en) * | 2011-04-21 | 2016-03-10 | Abbvie Inc. | Wearable automatic injection device |
CN103732275B (zh) * | 2011-06-17 | 2016-08-17 | Shl集团有限责任公司 | 注射设备 |
US9033934B2 (en) * | 2011-09-27 | 2015-05-19 | Shl Group Ab | Medical delivery device with an initial locked state, intermediate priming state and a medicament delivery state |
KR101704153B1 (ko) | 2011-11-25 | 2017-02-22 | 에스에이치엘 그룹 에이비 | 약물 전달 장치 |
JP5945550B2 (ja) * | 2011-12-09 | 2016-07-05 | パナソニックヘルスケアホールディングス株式会社 | 薬剤シリンジユニットおよび薬剤注入装置 |
EP2790752B1 (en) * | 2011-12-15 | 2018-08-08 | SHL Group AB | Auto-injection device |
US8591463B1 (en) * | 2013-03-08 | 2013-11-26 | Teva Pharmaceutical Industries Ltd. | Re-useable injector device for syringe |
US10898646B2 (en) * | 2016-04-29 | 2021-01-26 | Shl Medical Ag | Container holder assembly |
-
2014
- 2014-09-26 GB GBGB1416985.8A patent/GB201416985D0/en not_active Ceased
-
2015
- 2015-09-21 BR BR112017006133-3A patent/BR112017006133B1/pt active IP Right Grant
- 2015-09-21 WO PCT/EP2015/071601 patent/WO2016046131A1/en active Application Filing
- 2015-09-21 EP EP15763950.1A patent/EP3197526B1/en active Active
- 2015-09-21 US US15/513,771 patent/US10918792B2/en active Active
- 2015-09-21 JP JP2017516775A patent/JP6461325B2/ja active Active
- 2015-09-21 CN CN201580051900.1A patent/CN107073215B/zh active Active
- 2015-09-21 AU AU2015320956A patent/AU2015320956A1/en not_active Abandoned
- 2015-09-21 CA CA2960782A patent/CA2960782C/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3052991U (ja) * | 1998-04-02 | 1998-10-13 | オージーケー技研株式会社 | ハンドルグリップ構造 |
JP2002518107A (ja) * | 1998-06-19 | 2002-06-25 | アボット・ラボラトリーズ | エラストマー製端部を備えた注入ポンプ用押出加工金属ハウジング |
JP2013522481A (ja) * | 2010-03-12 | 2013-06-13 | エクソンモービル・ケミカル・パテンツ・インク | 耐熱性不織布を生成するための方法 |
JP2012082262A (ja) * | 2010-10-07 | 2012-04-26 | Kaneka Corp | 熱可塑性樹脂組成物および成形体 |
JP2014506493A (ja) * | 2011-01-24 | 2014-03-17 | アッヴィ バイオテクノロジー リミテッド | オーバーモールド把持面を有する自動注射器 |
WO2014033141A1 (en) * | 2012-08-31 | 2014-03-06 | Sanofi-Aventis Deutschland Gmbh | Medical device with impact resistant housing |
Also Published As
Publication number | Publication date |
---|---|
AU2015320956A1 (en) | 2017-04-06 |
EP3197526B1 (en) | 2022-02-23 |
US20170239419A1 (en) | 2017-08-24 |
BR112017006133B1 (pt) | 2022-05-24 |
GB201416985D0 (en) | 2014-11-12 |
US10918792B2 (en) | 2021-02-16 |
CN107073215B (zh) | 2021-01-22 |
CA2960782C (en) | 2022-09-06 |
WO2016046131A1 (en) | 2016-03-31 |
BR112017006133A2 (pt) | 2018-01-30 |
CA2960782A1 (en) | 2016-03-31 |
CN107073215A (zh) | 2017-08-18 |
JP6461325B2 (ja) | 2019-01-30 |
EP3197526A1 (en) | 2017-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6461325B2 (ja) | 自動注射器用ハウジング部分 | |
EP3033127B1 (en) | Injector | |
WO2011012849A1 (en) | Injector | |
WO2010146358A2 (en) | Auto-injector | |
US11324896B2 (en) | Cap for an injector | |
WO2009081132A1 (en) | Auto- injector having a first coupling for coupling said drive transfer element to said syringe barrel | |
WO2009081133A1 (en) | Auto-injector with flexible element to restrict movement of the needle cover and to provide a barrier surface for obstructing exit of the syringe barrel | |
US11701476B2 (en) | Cap for medical injector | |
AU2008231910B2 (en) | Auto injector | |
US9132242B2 (en) | Auto-injector | |
JP2022516294A (ja) | シールドトリガ機構およびシールドトリガ機構を有する注射装置 | |
KR20240043760A (ko) | 약물 전달 장치 조립 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20170626 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20180427 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180511 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180802 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20181130 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20181225 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6461325 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |